The Radiologically Isolated Syndrome in Children
儿童放射孤立综合征
基本信息
- 批准号:9769164
- 负责人:
- 金额:$ 19.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAllelesAntibodiesAutoantibodiesAutoimmune DiseasesAwardBiological FactorsBiologyBody mass indexBrainBrain StemBrain scanCaliforniaCentral VeinCerebellumCerebrospinal FluidChildChildhoodChronicClinicalClinical ResearchClinical TrialsCohort StudiesCollaborationsCountryCraniocerebral TraumaDataDetectionDevelopmentDiagnosisEnhancing LesionEnrollmentEventEvolutionFamily history ofFellowshipFundingFutureGeneticGoalsHLA-DRB1Human Herpesvirus 4ImageImage AnalysisImaging TechniquesIncidental FindingsIndividualInfectionInfrastructureInternationalIntervention TrialLaboratoriesLesionLocationLongitudinal cohort studyMRI ScansMagnetic Resonance ImagingMentorsMigraineMultiple SclerosisMyelinNerve SheathsNeuraxisNeurologicNeurologic SymptomsNeurologistOligoclonal BandsOligodendrogliaOutcomePediatric HospitalsPediatric RadiologyPhiladelphiaProtocols documentationRaceRadiology SpecialtyRecruitment ActivityRelapseResearchResearch TechnicsRiskRisk FactorsScientistSerologicalSerumSiteSpinal CordSpinal Cord LesionsStandardizationSymptomsSyndromeTimeTrainingUnited States National Institutes of HealthUniversitiesVeinsVitamin Dclinical Diagnosisclinical developmentcohortdisabilityepidemiology studyexperienceimprovedmalemultiple sclerosis patientneuroimagingnovelpediatric multiple sclerosispreventprospectivesextheoriestoolwhite matter
项目摘要
PROJECT SUMMARY / ABSTRACT
Dr. Makhani is a pediatric neurologist whose long-term goal is to implement strategies to prevent multiple
sclerosis in children at risk. The training and mentored research experience proposed will enable her to
develop expertise in conducting longitudinal cohort studies and in using MRI as a clinical and research tool.
Dr. Makhani has assembled an expert and committed team of mentors and advisors to help her. Dr. Eugene
Shapiro, her primary mentor, is a recognized leader in clinical epidemiological research and Dr. Daniel Pelletier
(co-mentor) is a world expert in using MRI to study the biology of multiple sclerosis. Dr. Makhani will take
courses at Yale on the theory and application of use of imaging techniques in neurological research and will
spend six months with Dr. Pelletier getting hands-on training in his Advanced Imaging in Multiple Sclerosis lab
at the University of Southern California. She will also take advanced courses at Yale in genetics, as well as in
the analysis of imaging data, of longitudinal data, of time-to-event data and of clinical trials.
Children with multiple sclerosis, the most common autoimmune disease of the central nervous system,
have high relapse rates and may develop disability at a young age, but treatment may improve both. The
typical MRI findings of multiple sclerosis have been found in people without any symptoms of multiple sclerosis
who underwent MRI scans of the brain for other reasons (e.g., head trauma). This clinical scenario has been
termed the radiologically isolated syndrome (RIS). Among adults with RIS, 34% developed clinical neurological
symptoms consistent with multiple sclerosis within five years of the initial abnormal MRI. In adults with RIS,
age <37 years, male sex and spinal cord lesions on MRI were associated with developing clinical neurological
symptoms. We do not know either the risk of or what factors are associated with developing a clinical diagnosis
of multiple sclerosis in children with RIS.
We will conduct a mixed historical and prospective longitudinal cohort study to determine both the
likelihood of and the factors (clinical, demographic, MRI, laboratory and genetic) associated with the
development of a clinical diagnosis of multiple sclerosis in children with RIS. This study will help determine
which children with RIS are at greatest risk of a clinical multiple sclerosis and will set the stage for intervention
trials to prevent or to delay onset of clinical multiple sclerosis in these children. Upon completion of this award,
Dr. Makhani will be the only pediatric neurologist in the world with formal fellowship training in pediatric multiple
sclerosis and formal training in using neuroimaging techniques for research in pediatric multiple sclerosis. She
will have conducted the first and only longitudinal cohort study of children with RIS in collaboration with her
Pediatric RIS Consortium, that will provide the necessary infrastructure for future studies, and she will be well
poised to apply for funding to become an independent clinician-scientist.
项目总结/摘要
Makhani博士是一名儿科神经学家,其长期目标是实施预防多发性硬化的策略。
有患硬化症风险的儿童。建议的培训和指导研究经验将使她能够
发展进行纵向队列研究和使用MRI作为临床和研究工具的专业知识。
博士Makhani已经组建了一个专家团队,由导师和顾问组成,致力于帮助她。尤金博士
夏皮罗,她的主要导师,是一个公认的领导人在临床流行病学研究和博士丹尼尔佩尔蒂埃
他是一位世界级的专家,擅长利用核磁共振成像研究多发性硬化症的生物学。马哈尼医生会
课程在耶鲁大学的理论和应用成像技术在神经学研究中的使用,并将
我花了六个月的时间在Pelletier博士的多发性硬化症高级成像实验室接受实践培训
在南加州大学。她还将参加耶鲁大学遗传学高级课程,以及
成像数据、纵向数据、事件发生时间数据和临床试验的分析。
儿童多发性硬化症是中枢神经系统最常见的自身免疫性疾病,
复发率高,可能在年轻时发展为残疾,但治疗可能会改善两者。的
在没有任何多发性硬化症症状的人群中发现了多发性硬化症的典型MRI表现
因其他原因接受脑部MRI扫描的患者(例如,头部创伤)。这种临床情况一直是
放射学孤立综合征(RIS)。在患有RIS的成年人中,34%的人发展为临床神经系统疾病,
在最初MRI异常的五年内出现与多发性硬化症一致的症状。在患有RIS的成人中,
年龄<37岁、男性和MRI上的脊髓病变与临床神经系统疾病的发生相关
症状我们不知道风险或什么因素与临床诊断有关
多发性硬化症的发病率
我们将进行一项混合的历史和前瞻性纵向队列研究,以确定
可能性和相关因素(临床、人口统计学、MRI、实验室和遗传)
RIS儿童多发性硬化症的临床诊断。这项研究将有助于确定
哪些患有RIS的儿童患临床多发性硬化症的风险最大,并将为干预奠定基础
在这些儿童中进行预防或延迟临床多发性硬化症发作的试验。在完成这项奖励后,
博士Makhani将是世界上唯一一位在儿科多学科领域接受过正式奖学金培训的儿科神经学家。
在儿童多发性硬化症的研究中使用神经成像技术的正规培训。她
将与她合作,对患有RIS的儿童进行第一次也是唯一一次纵向队列研究。
儿科RIS联盟,这将为未来的研究提供必要的基础设施,她会很好
准备申请资金成为一名独立的临床科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naila Makhani其他文献
Naila Makhani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naila Makhani', 18)}}的其他基金
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Research Grant